Lilly results add to buzz around weight loss drugs

The emerging anti-obesity drug market is already having downstream effects. In its annual Impact of Change Forecast, analysts at Sg2 estimate a 4% drop in bariatric surgeries over the next decade because of the anti-obesity drugs.